Skip to main content

Nicorandil versus nitroglycerin: a pilot study

Introduction

Continuous exposure to nitrates is associated with tachyphylaxis. This study compares the effects and tolerance during intravenous treatment with nitroglycerin and nicorandil over a 48-hour period.

Methods

Twenty patients with congestive heart failure and pulmonary capillary wedge pressure (PCWP) ≥18 mmHg were randomly assigned to nitroglycerin or nicorandil intravenous infusions. Doses were titrated to obtain a reduction of PCWP of at least 30% at 6 hours and then maintained for 48 hours.

Results

There was no statistical difference between the groups in terms of age, sex, and NYHA grade. The pretreatment PCWP for nitroglycerin was 25.7 mmHg, decreasing to 18.4 mmHg at 6 hours. The values for nicorandil were 25.4 mmHg and 17.3 mmHg, respectively. There was no statistical difference between the two groups (P = 0.79 pretreatment and 0.23 at 6 hours). The mean PCWP values for 24 hours were 19.7 and 17.4, respectively, which was statistically significant (P = 0.036). Similarly, the values for 48 hours were 20.6 and 17.9, which was significant (P = 0.026) (see Table 1).

Table 1 PCWP values before and after treatment

Conclusions

Intravenous nicorandil administration gives similar reductions in PCWP compared with nitroglycerin with significantly less haemodynamic tolerance over a 48-hour period compared with nitroglycerin. This might represent a clinical advantage of nicorandil in the short-term treatment of patients with congestive heart failure.

References

  1. 1.

    Tsutamoto T, Kinoshita M, Nakae I, et al.: Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure. Am Heart J 1994,127(4 Pt 1):866-873. 10.1016/0002-8703(94)90555-X

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to V Singh.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Singh, V., Momin, S. & Shah, B. Nicorandil versus nitroglycerin: a pilot study. Crit Care 15, P88 (2011). https://doi.org/10.1186/cc9508

Download citation

Keywords

  • Public Health
  • Nitrate
  • Pilot Study
  • Statistical Difference
  • Congestive Heart Failure